Analyzer and Atellica IM 1600 Analyzer system for in vitro diagnostic testing of clinical specimens.
Published May 9, 2018 · Recall initiated: February 26, 2018
Summary
FDA records medical device Class II recall Z-1588-2018, published May 9, 2018 and initiated February 26, 2018. Recalling firm: Siemens Healthcare Diagnostics, Inc.; Status: Terminated; Reported quantity: N/A; Lot: UDI 00630414002026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
When more than one immunoassay analyzer is connected to a single solution system, reporting and conversion factors may not be applied to all analyzers
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Siemens Healthcare Diagnostics, Inc.
- Distributor
- FL and France Spain Sweden United Kingdom Germany
- Lot
- UDI 00630414002026
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAAtellica CH Revised C-Reactive Protein (RCRP); Siemens Material Number (SMN): 11537223;October 7, 2026
- FDABeckman Coulter, Emit 2000 Quinidine Assay REF: OSR4Q229 Contents: R1: 2 x 23 mL;R2 2x13 mLAugust 26, 2026
- FDASyva EMIT 2000 Quinidine Assay REF: 4Q019UL Contents: 1x28 mL, 1x14mLAugust 26, 2026
- FDASyva Emit tox Serum Tricyclic Antidepressant Calibrator/Controls SMN 10445390 Catalog No. 7C219ULAugust 12, 2026
- FDAAQURE, Software version 2.3.0 and 2.3.1 Product Usage: The AQURE system is intended to let allow theMay 9, 2018
- FDAAllura Xper R8.x.25.5 and UNIZ systems (only with a FlexVision large screen monitor), InterventionalMay 9, 2018
Questions about this recall
Was Analyzer and Atellica IM 1600 Analyzer system for in vitro diagnostic testing of clinical specimens. recalled?
Yes. FDA published recall Z-1588-2018 on May 9, 2018. Reported hazard: When more than one immunoassay analyzer is connected to a single solution system, reporting and conversion factors may not be applied to all analyzers
What should I do if I have this product?
Voluntary: Firm initiated · Letter